Senior insider sale
EVP and Chief Legal Officer at ULTRAGENYX PHARMACEUTICAL INC. — senior position signals high conviction
$76.4K
2.45K shares
What this filing means
PARSCHAUER KARAH HERDMAN plans to sell 2.45K shares of ULTRAGENYX PHARMACEUTICAL INC. valued at approximately $76.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/12/2025ACC: 0001950047-25-007039
Officer· EVP and Chief Legal Officer
Since Mar 2026
2.45K
Shares to sell
$76.4K
Approx. market value
2.45K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Performance Shares
Not Applicable
3/1/2025
2.45KTotal acquired2.45K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/1/2025 | Performance Shares Not Applicable | 2.45K | — |
| Total | 2.45K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.45K
Market value
$76.4K
9/12/2025
Total
Units
2.45K
Value
$76.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/12/2025 | 2.45K | $76.4K | NASDAQ | Planned |
| Total | 2.45K | $76.4K | ||